Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dwayne L Barber

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|December 2, 2015
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismLianne E Rotin, Marcela Gronda, Neil MacLean, et al.
Blood|August 1, 2002
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathwaysJenny M-Y Ho, Melody H-H Nguyen, Jamil K Dierov, et al.
Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.
Experimental Hematology|September 20, 2011
Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screensNicole M Anderson, Zorana Berberovic, Elizabeth Berndl, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Molecular Therapy. Methods & Clinical Development|February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry diseaseAmr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Plos One|October 3, 2013
Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 alleleNicole M Anderson, Mojib Javadi, Elizabeth Berndl, et al.
Experimental Hematology|January 4, 2011
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosisMichael R Hughes, Nicole Anderson, Steven Maltby, et al.
Nature Medicine|June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemiaRyan C Russell, Roxana I Sufan, Bing Zhou, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|December 2, 2015
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismLianne E Rotin, Marcela Gronda, Neil MacLean, et al.
Blood|August 1, 2002
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathwaysJenny M-Y Ho, Melody H-H Nguyen, Jamil K Dierov, et al.
Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.
Experimental Hematology|September 20, 2011
Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screensNicole M Anderson, Zorana Berberovic, Elizabeth Berndl, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of riskDenis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Molecular Therapy. Methods & Clinical Development|February 23, 2023
Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry diseaseAmr H Saleh, Michael Rothe, Dwayne L Barber, et al.
Blood|September 19, 2007
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitinXinliang Mao, A Keith Stewart, Rose Hurren, et al.
Plos One|October 3, 2013
Enu mutagenesis identifies a novel platelet phenotype in a loss-of-function Jak2 alleleNicole M Anderson, Mojib Javadi, Elizabeth Berndl, et al.
Experimental Hematology|January 4, 2011
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosisMichael R Hughes, Nicole Anderson, Steven Maltby, et al.
Nature Medicine|June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemiaRyan C Russell, Roxana I Sufan, Bing Zhou, et al.
Pageof 5